The company is raising its share repurchase expectations in fiscal year 2025 by $250 million to $750 million. Overall, 2025 revenue is expected to grow between 10%-12 ...

Drug companies and specialty distributors navigate challenges like profitability, supply chain volatility, regulatory complexities, and market pressures to build successful partnerships, said Natalie ...

PITTSBURGH, Dec. 6, 2024 /PRNewswire/ -- PANTHERx® Rare, a leader in rare disease product patient access and support services in the United States, is pleased to announce it is partnering with ...

CC Pharma Agreement Bolsters Tilray’s UK Growth, Strengthening Distribution to Pharmacy and Hospital ChannelsNEW YORK and LONDON, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Tilray Pharma the pharmaceutical ...

ATHENS, Greece--(BUSINESS WIRE)--GENESIS Pharma, a leading regional biopharma company operating in Europe, and Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on ...

Pharma distribution is evolving. Discover how digital commerce is transforming traditional models—streamlining operations, cutting costs, and delivering patient-centric experiences. Pharmaceutical ...

ITASCA, Ill., Jan. 21, 2025 /PRNewswire/ -- Lakeside Holding Limited ("Lakeside" or the "Company") (Nasdaq: LSH), a U.S.-based cross-border supply chain solution provider with a unique focus on the ...

Riad Armanious, CEO of EVA Pharma and Wouter Latour, CEO of PharmaJet shake hands after signing the distribution agreement to provide PharmaJet Needle-free Injection Systems for routine polio ...

ATHENS, Greece--(BUSINESS WIRE)--GENESIS Pharma, a regional biopharma company specialized in the commercialization of innovative medicines targeting severe and rare diseases in Central and Eastern ...

CC Pharma’s selection as a TOP 100 Innovator reflects its disciplined innovation strategy, strong regional footprint, and commitment to operational excellence in a highly regulated market. The award ...

Wednesday, Cardinal Health Inc (NYSE:CAH) reported fourth-quarter 2024 adjusted EPS of $1.84, up 29% year over year, beating the consensus of $1.73. Cardinal Health is a distributor of pharmaceuticals ...